Effectiveness and safety of guselkumab for the treatment of psoriasis in real-world settings at 24 weeks: A retrospective, observational, multicentre study by the Spanish Psoriasis Group

Colaboración

Año: 2022

del Alcazar, E; Lopez-Ferrer, A; Martinez-Domenech, A; Ruiz-Villaverde, R; Llamas-Velasco, MD; Rocamora, V; Julia, M; Notario, J; Fernandez-Freire, LR; Sahuquillo-Torralba, A; Vidal, D; Rivera, R; Carretero, G; Mateu, A; de la Cueva, P; Carrascosa, JM

Título: DERMATOLOGIC THERAPY

• Q2